A fight by the U.S. Federal Trade Commission to make public a Georgia pharmaceutical company's copnfidential memo detailing a strategy to pay rival drug companies not to compete has become part of a larger antitrust battle that has now reached the U.S. Supreme Court.
FTC continues fight to unseal Solvay memo on paying rivals
January 14, 2013
This article requires premium access
This article requires premium access to Daily Report. Please sign in or subscribe to read the full text.